Result of venetoclax plus/minus azacitidine for R/R MDS
Amer Zeidan, MBBS, MHS, Yale University and Yale Cancer Center, New Haven, CT, discusses the updated data from the ongoing…
Related Articles
IL-10 in Systemic Lupus Erythematosus: Balancing Immunoregulation and Autoimmunity
Interleukin-10 (IL-10) presents a dual role in systemic lupus erythematosus (SLE), illustrating pro-inflammatory and anti-inflammatory effects. This study addressed the possible associations between serum IL-10…
Desmoplastic Melanoma: 5-Minute Pathology Pearls
A complete organized library of all my videos, digital slides, pics, & sample pathology reports is available here: https://kikoxp.com/posts/5084 (dermpath) &…
More Everything Forever: AI Overlords, Space Empires, and Silicon Valley’s Crusade to Control the Fate of Humanity
Tech billionaires have decided that they should determine our futures for us. According to Elon Musk, Jeff Bezos, Sam Altman, and more, the only good…
Frontiers | Keloids and inflammation: the crucial role of IL-33 in epidermal changes
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Introduction: Keloids are benign fibroproliferative disorders…
Debra Patt: Excited to be part of South by Southwest – OncoDaily
Debra Patt: Excited to be part of South by Southwest / cancer, Debra Patt, Johnson and Johnson, OncoDaily, Oncology, South by Southwest, Texas Oncology, The
Tumor “age” in early-onset colorectal cancer
The incidence of early-onset colorectal cancer (EO-CRC) is surging, and by 2030, one-third of all CRCs will occur before the commonly recommended screening age of…
Razelle Kurzrock: DART did it again! – OncoDaily
Razelle Kurzrock: DART did it again! / Adedayo A Onitilo, Adrienne I. Victor, Benjamin C Powers, cancer, Charles D Blanke, Christine M. McLeod, Christopher D
Danielle Townsley MD MSc on LinkedIn: #precisionmedicine #amgen
I am hiring in my team! Its never been a more exciting time to work at the intersection of technology and drug development. If you…
Stephanie Graff: Excited to have another therapeutic option to treat advanced HR+ breast cancer – OncoDaily
Stephanie Graff: Excited to have another therapeutic option to treat advanced HR+ breast cancer / Breast Cancer, cancer, Datopotumab deruxtecan, FDA, HR+
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer – OncoDaily
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer / Aarti R. Chawla, Abemaciclib, Bastien Nguyen, Breast Cancer, cancer, Cynthia Sandoval, Dana-Farber’s